These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18507019)
1. Bone marrow-derived endothelial cells contribute to angiogenesis in murine WEHI and JC tumors. Stoelting S; Heinze G; Nadrowitz R; Wagner T; Peters SO Anticancer Res; 2008; 28(2A):771-7. PubMed ID: 18507019 [TBL] [Abstract][Full Text] [Related]
2. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Peters BA; Diaz LA; Polyak K; Meszler L; Romans K; Guinan EC; Antin JH; Myerson D; Hamilton SR; Vogelstein B; Kinzler KW; Lengauer C Nat Med; 2005 Mar; 11(3):261-2. PubMed ID: 15723071 [TBL] [Abstract][Full Text] [Related]
3. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866 [TBL] [Abstract][Full Text] [Related]
4. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Hu Y; Davison F; Zhang Z; Xu Q Circulation; 2003 Dec; 108(25):3122-7. PubMed ID: 14656919 [TBL] [Abstract][Full Text] [Related]
5. Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization. Espinosa-Heidmann DG; Reinoso MA; Pina Y; Csaky KG; Caicedo A; Cousins SW Exp Eye Res; 2005 Mar; 80(3):369-78. PubMed ID: 15721619 [TBL] [Abstract][Full Text] [Related]
6. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Li H; Gerald WL; Benezra R Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Santarelli JG; Udani V; Yung YC; Cheshier S; Wagers A; Brekken RA; Weissman I; Tse V Neurosurgery; 2006 Aug; 59(2):374-82; discussion 374-82. PubMed ID: 16883178 [TBL] [Abstract][Full Text] [Related]
8. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J Hum Reprod; 2008 Jan; 23(1):139-43. PubMed ID: 17981818 [TBL] [Abstract][Full Text] [Related]
9. Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Dwenger A; Rosenthal F; Machein M; Waller C; Spyridonidis A Stem Cells; 2004; 22(1):86-92. PubMed ID: 14688394 [TBL] [Abstract][Full Text] [Related]
10. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035 [TBL] [Abstract][Full Text] [Related]
11. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Jodele S; Chantrain CF; Blavier L; Lutzko C; Crooks GM; Shimada H; Coussens LM; Declerck YA Cancer Res; 2005 Apr; 65(8):3200-8. PubMed ID: 15833851 [TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Yoder MC; Ingram DA Curr Opin Hematol; 2009 Jul; 16(4):269-73. PubMed ID: 19417649 [TBL] [Abstract][Full Text] [Related]
13. Selective advantage of normal erythrocyte production after bone marrow transplantation of alpha-thalassemic mice. van den Bos C; Kieboom D; van der Sluijs JP; Baert MR; Ploemacher RE; Wagemaker G Exp Hematol; 1994 May; 22(5):441-6. PubMed ID: 8174674 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. Miyamoto Y; Suyama T; Yashita T; Akimaru H; Kurata H J Mol Cell Cardiol; 2007 Nov; 43(5):627-35. PubMed ID: 17900610 [TBL] [Abstract][Full Text] [Related]
15. The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Carmeliet P; Luttun A Thromb Haemost; 2001 Jul; 86(1):289-97. PubMed ID: 11487017 [TBL] [Abstract][Full Text] [Related]
16. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo. Zhou Z; Reddy K; Guan H; Kleinerman ES Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258 [TBL] [Abstract][Full Text] [Related]
17. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy]. Farace F; Bidart JM Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012 [TBL] [Abstract][Full Text] [Related]
18. Cardiac myocytes are recruited by bone marrow-derived cells in intact murine heart. Satomi-Kobayashi S; Kawashima S; Sakoda T; Ueyama T; Kawai M; Toh R; Azumi H; Mizutani K; Hattori K; Yokoyama M Kobe J Med Sci; 2002 Dec; 48(5-6):161-6. PubMed ID: 12657833 [TBL] [Abstract][Full Text] [Related]
19. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777 [TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]